Schnadig相关文献与解析，生知库 | 链接生命科学的每一步

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

恩扎卢胺联合沙莫托利西布（LY3023414）或安慰剂治疗转移性去势抵抗性前列腺癌患者的Ib/II期研究

Sweeney, Christopher J; Percent, Ivor J; Babu, Sunil; Cultrera, Jennifer L; Mehlhaff, Bryan A; Goodman, Oscar B; Morris, David S; Schnadig, Ian D; Albany, Costantine; Shore, Neal D; Sieber, Paul R; Guba, Susan C; Zhang, Wei; Wacheck, Volker; Donoho, Gregory P; Szpurka, Anna M; Callies, Sophie; Lin, Boris Kin; Bendell, Johanna C

肿瘤

Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations

罗拉匹坦临床药理学的最新进展：特定人群的亚组分析

期刊:Drug Design Development and Therapy

影响因子:5.1

doi:10.2147/DDDT.S133943

Rapoport, Bernardo Leon; Aapro, Matti; Chasen, Martin R; Jordan, Karin; Navari, Rudolph M; Schnadig, Ian; Schwartzberg, Lee

发表日期：2017

文献求助收藏

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy

罗拉匹坦可改善接受高致吐性或中度致吐性化疗患者的生活质量

期刊:Supportive Care in Cancer

影响因子:3

doi:10.1007/s00520-016-3388-7

Chasen, Martin; Urban, Laszlo; Schnadig, Ian; Rapoport, Bernardo; Powers, Dan; Arora, Sujata; Navari, Rudolph; Schwartzberg, Lee; Gridelli, Cesare

发表日期：2017

文献求助收藏

APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial

在指南推荐的三药联合方案中，APF530 与昂丹司琼用于预防蒽环类药物联合环磷酰胺类高致吐性化疗方案引起的化疗相关恶心呕吐：一项 III 期随机 MAGIC 试验的事后亚组分析

期刊:Cancer Management and Research

影响因子:2.6

doi:10.2147/CMAR.S129059

Schnadig, Ian D; Agajanian, Richy; Dakhil, Christopher; Gabrail, Nashat; Vacirca, Jeffrey; Taylor, Charles; Wilks, Sharon; Braun, Eduardo; Mosier, Michael C; Geller, Robert B; Schwartzberg, Lee; Vogelzang, Nicholas

MAG

发表日期：2017

文献求助收藏

Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy

神经激肽-1受体拮抗剂罗拉匹坦预防接受卡铂化疗患者恶心呕吐的疗效

期刊:Cancer

影响因子:5.1

doi:10.1002/cncr.30054

Hesketh, Paul J; Schnadig, Ian D; Schwartzberg, Lee S; Modiano, Manuel R; Jordan, Karin; Arora, Sujata; Powers, Dan; Aapro, Matti

信号转导

发表日期：2016

文献求助收藏

A case of peripheral T-cell lymphoma, not otherwise specified in a HCV and HTLV-II-positive patient, diagnosed by abdominal fluid cytology

一例HCV和HTLV-II阳性患者，经腹腔积液细胞学检查确诊为外周T细胞淋巴瘤（未另行分类）。

期刊:Journal of Gastrointestinal Oncology

影响因子:2

doi:10.3978/j.issn.2078-6891.2015.054

Ameri, Maryam Dadfarnia; Parekh, Trisha M; Qian, You-Wen; Elghetany, M Tarek; Schnadig, Vicki; Nawgiri, Ranjina

A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

一项随机、II期临床试验，旨在评估多西他赛联合或不联合不可逆口服磷脂酰肌醇3-激酶抑制剂PX-866治疗复发或转移性头颈部鳞状细胞癌患者的疗效。

期刊:Oral Oncology

影响因子:3.9

doi:10.1016/j.oraloncology.2014.12.013

Jimeno, Antonio; Bauman, Julie E; Weissman, Charles; Adkins, Douglas; Schnadig, Ian; Beauregard, Patrice; Bowles, Daniel W; Spira, Alexander; Levy, Benjamin; Seetharamu, Nagashree; Hausman, Diana; Walker, Luke; Rudin, Charles M; Shirai, Keisuke

Clinical outcomes with bevacizumab-containing and non-bevacizumab-containing regimens in patients with recurrent glioblastoma from US community practices

美国社区诊所中，含贝伐单抗和不含贝伐单抗方案治疗复发性胶质母细胞瘤患者的临床结果

期刊:Journal of Neuro-Oncology

影响因子:3.1

doi:10.1007/s11060-015-1752-y

Chen, Clara; Ravelo, Arliene; Yu, Elaine; Dhanda, Rahul; Schnadig, Ian

细胞生物学

发表日期：2015

文献求助收藏

Is fine needle aspiration cytology a useful diagnostic tool for granular cell tumors? A cytohistological review with emphasis on pitfalls

细针穿刺细胞学检查是颗粒细胞瘤的有效诊断工具吗？一篇细胞组织学综述，重点关注其局限性。

期刊:Cytojournal

影响因子:3.1

doi:10.4103/1742-6413.143304

Koshy, Jason; Schnadig, Vicki; Nawgiri, Ranjana

Ethical issues in collecting data used in epidemiological studies

流行病学研究中数据收集的伦理问题

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

恩扎卢胺联合沙莫托利西布（LY3023414）或安慰剂治疗转移性去势抵抗性前列腺癌患者的Ib/II期研究

Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations

罗拉匹坦临床药理学的最新进展：特定人群的亚组分析

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy

罗拉匹坦可改善接受高致吐性或中度致吐性化疗患者的生活质量

APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial

在指南推荐的三药联合方案中，APF530 与昂丹司琼用于预防蒽环类药物联合环磷酰胺类高致吐性化疗方案引起的化疗相关恶心呕吐：一项 III 期随机 MAGIC 试验的事后亚组分析

Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy

神经激肽-1受体拮抗剂罗拉匹坦预防接受卡铂化疗患者恶心呕吐的疗效

A case of peripheral T-cell lymphoma, not otherwise specified in a HCV and HTLV-II-positive patient, diagnosed by abdominal fluid cytology

一例HCV和HTLV-II阳性患者，经腹腔积液细胞学检查确诊为外周T细胞淋巴瘤（未另行分类）。

A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

一项随机、II期临床试验，旨在评估多西他赛联合或不联合不可逆口服磷脂酰肌醇3-激酶抑制剂PX-866治疗复发或转移性头颈部鳞状细胞癌患者的疗效。

Clinical outcomes with bevacizumab-containing and non-bevacizumab-containing regimens in patients with recurrent glioblastoma from US community practices

美国社区诊所中，含贝伐单抗和不含贝伐单抗方案治疗复发性胶质母细胞瘤患者的临床结果

Is fine needle aspiration cytology a useful diagnostic tool for granular cell tumors? A cytohistological review with emphasis on pitfalls

细针穿刺细胞学检查是颗粒细胞瘤的有效诊断工具吗？一篇细胞组织学综述，重点关注其局限性。